NDC 0270-0091

CardioGen-82

Rubidium Chloride Rb-82

CardioGen-82 is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bracco Diagnostics Inc. The primary component is Rubidium Chloride Rb-82.

Product ID0270-0091_1e803554-7690-9ab8-6acc-1bb7188d4078
NDC0270-0091
Product TypeHuman Prescription Drug
Proprietary NameCardioGen-82
Generic NameRubidium Chloride Rb-82
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date1989-12-30
Marketing CategoryNDA / NDA
Application NumberNDA019414
Labeler NameBracco Diagnostics Inc
Substance NameRUBIDIUM CHLORIDE RB-82
Active Ingredient Strength150 mCi/1
Pharm ClassesRadioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0270-0091-01

1 INJECTION, SOLUTION in 1 PACKAGE (0270-0091-01)
Marketing Start Date1989-12-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0270-0091-01 [00270009101]

CardioGen-82 INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019414
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1989-12-30

Drug Details

Active Ingredients

IngredientStrength
RUBIDIUM CHLORIDE RB-82150 mCi/1

OpenFDA Data

SPL SET ID:ee95aa18-9f2f-40eb-9b4c-583bea6f36bf
Manufacturer
UNII

Pharmacological Class

  • Radioactive Diagnostic Agent [EPC]
  • Radiopharmaceutical Activity [MoA]

Trademark Results [CardioGen-82]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CARDIOGEN-82
CARDIOGEN-82
88368061 not registered Live/Pending
Bracco Diagnostics Inc.
2019-04-02
CARDIOGEN-82
CARDIOGEN-82
73557030 1390490 Live/Registered
E. R. SQUIBB & SONS, INC.
1985-09-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.